$13.65
-0.37-2.64%
al cierre: Nov 16, 4:00 PM EST
$13.65
N/A
After hour: 4:00 PM EST
The average analyst price target for BlossomHill Therapeutics is $34.17, 150.3% above the current price. Of 5 analysts, 5 rate it Buy. Targets range from $28 to $40. The latest change came on Sep 21, 2026, when Leerink Partners raised its price target on BlossomHill Therapeutics from $36 to $40 and kept an Outperform rating.
Price Target Range — 1 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months
